Connect your AI

Ormat Technologies ORA Deferred Finance Costs Noncurrent Net

Deferred Finance Costs Noncurrent Net at other companies

Clearwater AnalyticsCWAN

$3.27M+1,023%

Essential UtilitiesWTRG

$53.81M+15.0%

Jazz PharmaceuticalsJAZZ

$7.1M-21.1%

RayonierRYN

$4K—

TG TherapeuticsTGTX

$0—

Match GroupMTCH

$100K—

Other financials

Income statement

Revenue$403.9M+75.8%

Gross profit$120.4M+65.1%

Operating income$80.3M+57.6%

Net income$44.1M+9.2%

EPS (diluted)$0.71+7.6%

Balance sheet

Cash & equivalents$654.6M+481%

Total debt$46.4M+57.9%

Total equity$2.6B+4.5%

Total assets$6.8B+16.0%

Cash flow

Operating cash flow$78.6M-10.7%

CapEx$113.8M-40.9%

Free cash flow-$35.2M+66.3%

Valuation

Market cap$7.85B+60.3%

Enterprise value$7.24B+49.0%

P/E61.5×+22.5×

P/S6.7×+1.2×

Profitability

Gross margin27.5%-2.6pp

Operating margin17.1%-2.2pp

Net margin11%-3.2pp

FCF margin-18.5%—

Returns & leverage

Return on equity5.1%-0.1pp

Debt / equity0×0.0×

Current ratio1.1×+0.1×

Where this comes from

Reported directly by Ormat Technologies in its filing.

Tagged under the XBRL concept us-gaap:DeferredFinanceCostsNoncurrentNet.

The official record: Ormat Technologies’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ormat Technologies's deferred finance costs noncurrent net.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Ormat Technologies's deferred finance costs noncurrent net?: Ormat Technologies (ORA) reported deferred finance costs noncurrent net of $19.1M in Q1 2026.